Matches in UGent Biblio for { <https://biblio.ugent.be/publication/155697#aggregation> ?p ?o. }
Showing items 1 to 36 of
36
with 100 items per page.
- aggregation classification "A1".
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2002".
- aggregation format "application/pdf".
- aggregation hasFormat 155697.bibtex.
- aggregation hasFormat 155697.csv.
- aggregation hasFormat 155697.dc.
- aggregation hasFormat 155697.didl.
- aggregation hasFormat 155697.doc.
- aggregation hasFormat 155697.json.
- aggregation hasFormat 155697.mets.
- aggregation hasFormat 155697.mods.
- aggregation hasFormat 155697.rdf.
- aggregation hasFormat 155697.ris.
- aggregation hasFormat 155697.txt.
- aggregation hasFormat 155697.xls.
- aggregation hasFormat 155697.yaml.
- aggregation isPartOf urn:issn:0928-1231.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Evaluation of human albumin use in a university hospital in Belgium".
- aggregation abstract "In 1996 - 1997, a drug use evaluation (DUE) of human albumin was conducted in the Ghent University Hospital (Belgium) to determine the pattern and appropriateness of the albumin use. The DUE was followed by permanent review of the albumin consumption. This paper describes how the DUE was carried out and how the albumin use in our hospital changed over time. Method: The study was based on criteria for indications and end of treatment, accepted by consensus of the physicians prescribing albumin. Albumin treatment episodes were classified as appropriate or inappropriate according to these criteria. Results: For 115 treatment episodes in 90 patients, the researchers found 21 (18.3%) deviations from the developed criteria. After analysis, half out of them were considered as minor. Most deviations involved starting treatment too early (n = 17). Follow-up results indicated that the overall consumption of albumin dropped by 50.1% from 1994 to 1999, while the consumption of colloid solutions during the same period remained stable. Conclusion: A good compliance with internally developed criteria for indications and end of treatment with human albumin was observed. Discussion with the clinicians involved led to the development of stricter criteria and a continuous decrease in albumin consumption.".
- aggregation authorList BK262285.
- aggregation endPage "116".
- aggregation issue "3".
- aggregation startPage "111".
- aggregation volume "24".
- aggregation aggregates 917064.
- aggregation isDescribedBy 155697.
- aggregation similarTo A:1016120917510.
- aggregation similarTo LU-155697.